GlobalData on MSN
Raising the bar: can higher drug spending in the UK deliver for pharma and patients?
The UK considers raising NICE’s cost-effectiveness threshold, testing the balance between funding innovation and conserving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback